Equities

NeuroScientific Biopharmaceuticals Ltd

NSB:ASX

NeuroScientific Biopharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.048
  • Today's Change-0.004 / -7.69%
  • Shares traded377.70k
  • 1 Year change-34.25%
  • Beta0.3513
Data delayed at least 20 minutes, as of Apr 26 2024 06:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • NSB:ASX price falls below 50-day moving average to 0.048 at 11:25 BST
  • NSB:ASX price moved over +1.92% to 0.053

Key statistics

On Friday, NeuroScientific Biopharmaceuticals Ltd (NSB:ASX) closed at 0.048, 37.14% above the 52 week low of 0.035 set on Feb 26, 2024.
52-week range
Today
0.035Feb 26 20240.14Jul 19 2023
Open0.051
High0.051
Low0.048
Bid0.048
Offer0.052
Previous close0.052
Average volume453.13k
Shares outstanding144.60m
Free float94.22m
P/E (TTM)8.89
Market cap6.94m AUD
EPS (TTM)0.0054
AUD
Data delayed at least 20 minutes, as of Apr 26 2024 06:36 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.